JSJoaquim Soler

Joaquim Soler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joaquim Soler has a total of 466 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exploring user experiences of Kalmer: a focus group of an ecological momentary intervention app for non-suicidal self-injury

    by Anna Julià, Irene Jaén, Mónica Conesa, Azucena García-Palacios, Juan C. Pascual, Anna Sintes, Anaís Lara, Iria Méndez, Soledad Romero, Joaquim Puntí, et al.

  • Stand-alone dialectical behavior therapy skills training for borderline personality disorder: A systematic review and meta-analysis.

    by Maria Arqueros, Joaquim Soler, Juan C. Pascual

    Stand-alone dialectical behavior therapy skills training groups (DBT-ST) are widely used for borderline personality disorder (BPD), yet skills-specific benchmarks for symptom change and tolerability are unclear. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched PubMed, APA PsycARTICLES, APA PsycINFO, Psicodoc, and Psyke (English/Spanish) for adult stand-alone DBT-ST covering the four standard modules. Eligible designs were randomized clinical trials, controlled trials, and pre-post studies with standardized BPD diagnoses. Continuous outcomes were synthesized as standardized mean differences (Hedges-corrected d); within-arm pre-post effects used standardized mean change (assumed r = .50 when missing). Dropout was pooled on the logit scale and back transformed to retention. Random-effects model with Hartung-Knapp adjustments quantified heterogeneity and ran sensitivity/bias diagnostics. Seven studies met criteria; five entered meta-analysis. BPD clinical severity showed large within-arm improvement (d = -1.32, 95% confidence interval [CI; -1.99, -0.64]) with substantial heterogeneity. Depression decreased largely (k = 4; d = -1.04, 95% CI [-1.33, -0.75]); global psychopathology decreased moderately (k = 2; d = -0.73, 95% CI [-1.39, -0.08]). Pooled dropout was 29% (95% CI [23%, 36%]), implying 71% retention. Stand-alone DBT-ST is associated with large symptom reductions and acceptable retention, providing skills-specific benchmarks to inform implementation, whereas heterogeneity indicates the need for more robust comparative trials. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

  • Effects of a Dialectical Behavior Therapy Zen Retreat on Affect and Well-Being in Healthcare Workers

    by Karina Solovieff, Miguel Angel Murua, Maria Arqueros, Randy Wolbert, Jan Glasenapp, Vibh Forsythe, Joaquim Soler

  • Promoting self-compassion meditation with intranasal oxytocin in Borderline Personality Disorder: a pilot study

    by Maria Arqueros, Joaquim Soler, David Almenta, Anna Soria-Madrid, Carlos Schmidt, Juan C. Pascual

  • Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder

    by Joaquim Soler, Luis Borao, Carlos Schmidt, David Martinez-Rubio, Ausiàs Cebolla, Jesús Montero-Marin, Javier García-Campayo, Santiago Gascón-Santos, Juan C. Pascual


  • Open Access

    A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial

    by Anna Julià, Irene Jaén, Mónica Conesa Giménez, Azucena García-Palacios, Juan C Pascual, Anna Sintes Estévez, Anaís Lara, Iria Méndez, Soledad Romero, Joaquim Puntí, et al.

    Background: Nonsuicidal self-injury (NSSI), defined as the deliberate, self-inflicted damage of body tissue without suicidal intent, is increasingly prevalent among adolescents and young adults and poses a major public health concern. Current treatments are often costly, difficult to access, and not tailored to the specific needs of young people. Mobile health (mHealth) interventions represent a promising avenue for scalable, accessible, and cost-effective support for NSSI, especially when combined with real-time assessments and personalized treatment strategies. Objective: This randomized controlled trial will evaluate the effectiveness of Kalmer, a brief app-based intervention for reducing NSSI and improving emotional well-being. The study has 2 aims: (1) to evaluate a newly developed app-based intervention for adolescents and young adults engaging in NSSI and (2) to assess predictors of treatment outcomes for this app-based intervention. We hypothesize that participants receiving a mobile app–based brief intervention specifically tailored to address NSSI will show a greater reduction in NSSI frequency at the end of treatment and at follow-up than participants receiving a nonspecific app-based intervention. In this paper, we present our study protocol. Methods: This 2-arm randomized controlled trial, lasting 6 weeks, will include 240 participants aged 14 to 24 years who engage in NSSI. The intervention app, Kalmer, was developed through iterative consultation with clinical and research experts and guided by survey results and evidence-based frameworks such as dialectical behavior therapy and cognitive behavioral therapy. The intervention will include 5 core components: distress tolerance, emotion regulation, mindfulness and self-compassion, interpersonal regulation, and problem-focused coping. The app will deliver multimedia-based ecological momentary interventions triggered by real-time ecological momentary assessments to tailor support to users’ current contexts and needs. Participants are randomized to receive either the Kalmer intervention or a psychoeducational control app. The primary outcome will be NSSI frequency, assessed through self-report at baseline, 6 weeks after intervention, and at 1-month and 3-month follow-ups. Results: Ethics approval was obtained in December 2022. As of January 2026, a total of 145 participants had consented to participate in the study and completed baseline assessments. Preliminary data show high app engagement and acceptability and positive user feedback regarding app usability and content. Recruitment is ongoing. Conclusions: This study will provide evidence on the effectiveness of a mobile app–based intervention for NSSI and will explore potential mechanisms of change, supporting the development of accessible digital mental health tools for adolescents and young adults. Trial Registration: International Standard Randomized Controlled Trial Number Registry ISRCTN63093907; https://www.isrctn.com/ISRCTN63093907 International Registered Report Identifier (IRRID): DERR1-10.2196/86413


  • Open Access

    A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial (Preprint)

    by Anna Julià, Irene Jaén, Mónica Conesa Giménez, Azucena García-Palacios, Juan C Pascual, Anna Sintes Estévez, Anaís Lara, Iria Méndez, Soledad Romero, Joaquim Puntí, et al.

    BACKGROUND Nonsuicidal self-injury (NSSI), defined as the deliberate, self-inflicted damage of body tissue without suicidal intent, is increasingly prevalent among adolescents and young adults and poses a major public health concern. Current treatments are often costly, difficult to access, and not tailored to the specific needs of young people. Mobile health (mHealth) interventions represent a promising avenue for scalable, accessible, and cost-effective support for NSSI, especially when combined with real-time assessments and personalized treatment strategies. OBJECTIVE This randomized controlled trial will evaluate the effectiveness of Kalmer, a brief app-based intervention for reducing NSSI and improving emotional well-being. The study has 2 aims: (1) to evaluate a newly developed app-based intervention for adolescents and young adults engaging in NSSI and (2) to assess predictors of treatment outcomes for this app-based intervention. We hypothesize that participants receiving a mobile app–based brief intervention specifically tailored to address NSSI will show a greater reduction in NSSI frequency at the end of treatment and at follow-up than participants receiving a nonspecific app-based intervention. In this paper, we present our study protocol. METHODS This 2-arm randomized controlled trial, lasting 6 weeks, will include 240 participants aged 14 to 24 years who engage in NSSI. The intervention app, Kalmer, was developed through iterative consultation with clinical and research experts and guided by survey results and evidence-based frameworks such as dialectical behavior therapy and cognitive behavioral therapy. The intervention will include 5 core components: distress tolerance, emotion regulation, mindfulness and self-compassion, interpersonal regulation, and problem-focused coping. The app will deliver multimedia-based ecological momentary interventions triggered by real-time ecological momentary assessments to tailor support to users’ current contexts and needs. Participants are randomized to receive either the Kalmer intervention or a psychoeducational control app. The primary outcome will be NSSI frequency, assessed through self-report at baseline, 6 weeks after intervention, and at 1-month and 3-month follow-ups. RESULTS Ethics approval was obtained in December 2022. As of January 2026, a total of 145 participants had consented to participate in the study and completed baseline assessments. Preliminary data show high app engagement and acceptability and positive user feedback regarding app usability and content. Recruitment is ongoing. CONCLUSIONS This study will provide evidence on the effectiveness of a mobile app–based intervention for NSSI and will explore potential mechanisms of change, supporting the development of accessible digital mental health tools for adolescents and young adults. CLINICALTRIAL International Standard Randomized Controlled Trial Number Registry ISRCTN63093907; https://www.isrctn.com/ISRCTN63093907 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/86413

  • Scale to measure dialectical thinking from dialectical behavior therapy perspective.

    by Joaquim Soler, Maria Arqueros, Carlos Schmidt, Daniela Otero, Anna Soria-Madrid, María José Campins, Anna Catalan, Elisabet Casellas, Rocío Espeso, Juan Carlos Pascual


  • Open Access

    Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders

    by Fabian Streit, Swapnil Awasthi, Alisha Sm Hall, Alice Braun, Maria Niarchou, Eirini Marouli, Oladapo Babajide, Josef Frank, Lea Zillich, Carolin M Callies, et al.

    We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.